Cite
HARVARD Citation
Imberti, R. et al. (2014). Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria. Expert review of anti-infective therapy. 12 (4), pp. 471-478. [Online].